ResMed | RMD - Operating Expenses


ResMed reported $1.01B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Ansell USD 880.1M 465.65M Dec/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 143.94M 3.22M Jun/2026
Baxter International USD 2.68B 3.36B Jun/2026
Cochlear AUD 914.9M 454.8M Dec/2025
Cooper Companies USD 844.2M 268.3M Jun/2026
CSL USD 5.7B 2.82B Dec/2025
Dexcom USD 990.1M 53.5M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
Fisher Paykel Healthcare NZD 869.6M 67.2M Jun/2026
Globus Medical USD 835.58M 239.73M Jun/2026
Haemonetics USD 145.34M 148.66M Jun/2026
Idexx Laboratories USD 791.02M 12.78M Jun/2026
Inogen USD 49.14M 665K Sep/2024
Insulet USD 672M 32.3M Jun/2026
Integra LifeSciences USD 368.53M 674.84M Sep/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
Medtronic USD 7.92B 203M Jun/2026
Philips EUR 3.75B 147M Jun/2026
Ramsay Health Care AUD 8.8B 83.5M Dec/2025
ResMed USD 1.01B 83.57M Jun/2026
Sigma Healthcare AUD 1.68B 174.89M Dec/2024
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Steris USD 1.21B 62.8M Jun/2026
Teleflex USD 2.9B 179.9M Jun/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026